180 related articles for article (PubMed ID: 33811832)
21. Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma.
Castillo VF; Trpkov K; Van der Kwast T; Rotondo F; Hamdani M; Saleeb R
Pathol Int; 2024 Apr; 74(4):222-226. PubMed ID: 38456605
[TBL] [Abstract][Full Text] [Related]
22. Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity.
Al-Obaidy KI; Eble JN; Nassiri M; Cheng L; Eldomery MK; Williamson SR; Sakr WA; Gupta N; Hassan O; Idrees MT; Grignon DJ
Mod Pathol; 2020 Jun; 33(6):1157-1164. PubMed ID: 31534204
[TBL] [Abstract][Full Text] [Related]
23. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity.
Al-Obaidy KI; Saleeb RM; Trpkov K; Williamson SR; Sangoi AR; Nassiri M; Hes O; Montironi R; Cimadamore A; Acosta AM; Alruwaii ZI; Alkashash A; Hassan O; Gupta N; Osunkoya AO; Sen JD; Baldrige LA; Sakr WA; Idrees MT; Eble JN; Grignon DJ; Cheng L
Mod Pathol; 2022 Sep; 35(9):1279-1286. PubMed ID: 35152262
[TBL] [Abstract][Full Text] [Related]
24. Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review.
Li D; Liu F; Chen Y; Li P; Liu Y; Pang Y
Diagn Pathol; 2023 Nov; 18(1):120. PubMed ID: 37924117
[TBL] [Abstract][Full Text] [Related]
25. High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma.
Polifka I; Agaimy A; Herrmann E; Spath V; Trojan L; Stöckle M; Becker F; Ströbel P; Wülfing C; Schrader AJ; Barth P; Staehler M; Stief C; Hohenfellner M; Macher-Göppinger S; Wullich B; Noldus J; Brenner W; Roos FC; Walter B; Otto W; Burger M; Höfler H; Haferkamp A; Geppert CI; Stöhr C; Hartmann A;
Hum Pathol; 2019 Jan; 83():212-223. PubMed ID: 30121370
[TBL] [Abstract][Full Text] [Related]
26. Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease.
Chan E; Stohr BA; Butler RS; Cox RM; Myles JL; Nguyen JK; Przybycin CG; Reynolds JP; Williamson SR; McKenney JK
Am J Surg Pathol; 2022 Mar; 46(3):392-403. PubMed ID: 34881751
[TBL] [Abstract][Full Text] [Related]
27. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.
Skenderi F; Ulamec M; Vanecek T; Martinek P; Alaghehbandan R; Foix MP; Babankova I; Montiel DP; Alvarado-Cabrero I; Svajdler M; Dubinský P; Cempirkova D; Pavlovsky M; Vranic S; Daum O; Ondic O; Pivovarcikova K; Michalova K; Hora M; Rotterova P; Stehlikova A; Dusek M; Michal M; Hes O
Ann Diagn Pathol; 2017 Apr; 27():48-56. PubMed ID: 28325361
[TBL] [Abstract][Full Text] [Related]
28. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features.
Ren Q; Wang L; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
Am J Surg Pathol; 2018 Jun; 42(6):767-777. PubMed ID: 29462091
[TBL] [Abstract][Full Text] [Related]
29. "Mucin"-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases.
Pivovarcikova K; Peckova K; Martinek P; Montiel DP; Kalusova K; Pitra T; Hora M; Skenderi F; Ulamec M; Daum O; Rotterova P; Ondic O; Dubova M; Curik R; Dunatov A; Svoboda T; Michal M; Hes O
Virchows Arch; 2016 Jul; 469(1):71-80. PubMed ID: 27072821
[TBL] [Abstract][Full Text] [Related]
30. [Oncocytic papillary renal cell carcinoma: a clinicopathological analysis of nineteen cases].
Zhang W; Zhang LX; Yang T; Zou YW; Liu XL; Yu WJ; Jiang YX; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):981-986. PubMed ID: 36207910
[No Abstract] [Full Text] [Related]
31. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
[TBL] [Abstract][Full Text] [Related]
32. Papillary renal cell neoplasm with reverse polarity: A new subtype of renal tumour with favorable prognosis.
Conde-Ferreirós M; Domínguez-de Dios J; Juaneda-Magdalena L; Bellas-Pereira A; San Miguel Fraile MP; Peteiro Cancelo MÁ; Gómez-de María C; Álvarez Sarria M; Betancor Santos MÁ; González-Carreró J; Ortiz-Rey JA
Actas Urol Esp (Engl Ed); 2022 Dec; 46(10):600-605. PubMed ID: 36216763
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes.
Zhang K; Lee HM; Wei GH; Manninen A
Oncotarget; 2016 Dec; 7(51):84178-84189. PubMed ID: 27705936
[TBL] [Abstract][Full Text] [Related]
34. Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study.
Al-Obaidy KI; Eble JN; Cheng L; Williamson SR; Sakr WA; Gupta N; Idrees MT; Grignon DJ
Am J Surg Pathol; 2019 Aug; 43(8):1099-1111. PubMed ID: 31135486
[TBL] [Abstract][Full Text] [Related]
35. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
[TBL] [Abstract][Full Text] [Related]
36. Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases.
Peckova K; Martinek P; Pivovarcikova K; Vanecek T; Alaghehbandan R; Prochazkova K; Montiel DP; Hora M; Skenderi F; Ulamec M; Rotterova P; Daum O; Ferda J; Davidson W; Ondic O; Dubova M; Michal M; Hes O
Ann Diagn Pathol; 2017 Feb; 26():23-30. PubMed ID: 28038707
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological, genetic, ultrastructural characterizations and prognostic factors of papillary renal cell carcinoma: new diagnostic and prognostic information.
Yu W; Zhang W; Jiang Y; Wang Y; Li Y; Wang J; Sun L; Ran W; Li H
Acta Histochem; 2013 Jun; 115(5):452-9. PubMed ID: 23219441
[TBL] [Abstract][Full Text] [Related]
38. Papillary renal neoplasm with reverse polarity: A case report.
Xing C; Tian H; Zhang Y; Zhang L; Kong J
Front Oncol; 2023; 13():1072213. PubMed ID: 37143937
[TBL] [Abstract][Full Text] [Related]
39. Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases.
Alaghehbandan R; Ulamec M; Martinek P; Pivovarcikova K; Michalova K; Skenderi F; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2019 Feb; 38():80-86. PubMed ID: 30502717
[TBL] [Abstract][Full Text] [Related]
40. MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features.
Denize T; Just PA; Sibony M; Blons H; Timsit MO; Drossart T; Jakubowicz D; Broudin C; Morini A; Molina T; Vano Y; Auvray-Kuentz M; Richard S; Mejean A; Gimenez Roqueplo AP; Burnichon N; Verkarre V
Mod Pathol; 2021 Mar; 34(3):647-659. PubMed ID: 32770124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]